CLINICAL_TRIALS trial_result · 2023-04-21

Clinical Trial Update: A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery [Phase 2]

Phase 2 trial evaluating TAK-951 for prevention of postoperative nausea and vomiting (PONV) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Takeda | Conditions: Postoperative Nausea and Vomiting (PONV) | Phase 2 | Status: COMPLETED | Results posted: 2023-04-21